SPIRIT 1: An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Administered with and without Low-Dose Estradiol and Norethindrone Acetate in Women with Endometriosis-Associated Pain

Brief Description Of Study

Do You Have Pain Due to Endometriosis? Penn Women's Health Clinical Research Center is looking for women to participate in a research study to evaluate whether an investigational medicine could reduce pain due to endometriosis.

Detailed Study Description

To qualify, participants in this study will be woman who: -Are 18 to 50 years of age -Experience painful symptoms due to endometriosis -Have monthly menstrual periods -Had surgery in the last 10 years to look for endometriosis -Additional requirements apply Please call 215-615-3664 for more information and to find out if you are eligible to participate in the study.

Additional Information About The Study

If you are eligible, you will receive study medicine and study-related care at no cost to you and may be compensated for time and transportation.

ClinicalTrials.gov Identifier: NCT03204318


Contact research investigator to learn more about this study by filling out the form below.


To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: SPIRIT 1: An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Administered with and without Low-Dose Estradiol and Norethindrone Acetate in Women with Endometriosis-Associated Pain
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.